Neurogenic Pulmonary Edema After Electroconvulsive Therapy in 2 Young Patients

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Luciana Ramos Oliva ◽  
Maurício Fernando Lima Santos ◽  
Gustavo Carneiro-Gomes Leal
2012 ◽  
Vol 34 (6) ◽  
pp. 703.e9-703.e11 ◽  
Author(s):  
Tohru Takahashi ◽  
Kuni Kinoshita ◽  
Tomonori Fuke ◽  
Kazuhisa Urushihata ◽  
Tomoyuki Kawamata ◽  
...  

2006 ◽  
Vol preprint (2007) ◽  
pp. 1
Author(s):  
Henry Krous ◽  
Amy Chadwick ◽  
Douglas Miller ◽  
Laura Crandall ◽  
Hannah Kinney

2019 ◽  
Vol 130 (1) ◽  
pp. 83-91 ◽  
Author(s):  
Andreas Duma ◽  
Mathias Maleczek ◽  
Basil Panjikaran ◽  
Harald Herkner ◽  
Theodore Karrison ◽  
...  

Abstract EDITOR’S PERSPECTIVE What We Already Know about This Topic The incidence of major adverse cardiac events after electroconvulsive therapy is not known What This Article Tells Us That Is New Major adverse cardiac events and death after electroconvulsive therapy are infrequent and occur in about 1 of 50 patients and after about 1 of 200 to 500 electroconvulsive therapy treatments Background Cardiac events after electroconvulsive therapy have been reported sporadically, but a systematic assessment of the risk is missing. The goal of this study was to obtain a robust estimate of the incidence of major adverse cardiac events in adult patients undergoing electroconvulsive therapy. Methods Systematic review and meta-analysis of studies that investigated electroconvulsive therapy and reported major adverse cardiac events and/or mortality. Endpoints were incidence rates of major adverse cardiac events, including myocardial infarction, arrhythmia, pulmonary edema, pulmonary embolism, acute heart failure, and cardiac arrest. Additional endpoints were all-cause and cardiac mortality. The pooled estimated incidence rates and 95% CIs of individual major adverse cardiac events and mortality per 1,000 patients and per 1,000 electroconvulsive therapy treatments were calculated. Results After screening of 2,641 publications and full-text assessment of 284 studies, the data of 82 studies were extracted (total n = 106,569 patients; n = 786,995 electroconvulsive therapy treatments). The most commonly reported major adverse cardiac events were acute heart failure, arrhythmia, and acute pulmonary edema with an incidence (95% CI) of 24 (12.48 to 46.13), 25.83 (14.83 to 45.00), and 4.92 (0.85 to 28.60) per 1,000 patients or 2.44 (1.27 to 4.69), 4.66 (2.15 to 10.09), and 1.50 (0.71 to 3.14) per 1,000 electroconvulsive therapy treatments. All-cause mortality was 0.42 (0.11 to 1.52) deaths per 1,000 patients and 0.06 (0.02 to 0.23) deaths per 1,000 electroconvulsive therapy treatments. Cardiac death accounted for 29% (23 of 79) of deaths. Conclusions Major adverse cardiac events and death after electroconvulsive therapy are infrequent and occur in about 1 of 50 patients and after about 1 of 200 to 500 electroconvulsive therapy treatments.


Neurosurgery ◽  
1989 ◽  
pp. 762 ◽  
Author(s):  
H Touho ◽  
J Karasawa ◽  
H Shishido ◽  
K Yamada ◽  
Y Yamazaki

2002 ◽  
Vol 14 (3) ◽  
pp. 194-203 ◽  
Author(s):  
Bernhard Walder ◽  
Marie-Anne Bründler ◽  
Martin Tötsch ◽  
Nadia Elia ◽  
Denis R. Morel

2000 ◽  
Vol 172 (1) ◽  
pp. 73-76 ◽  
Author(s):  
Jun-ichi Inobe ◽  
Toshio Mori ◽  
Hidetsugu Ueyama ◽  
Toshihide Kumamoto ◽  
Tomiyasu Tsuda

2001 ◽  
Vol 40 (8) ◽  
pp. 826-828 ◽  
Author(s):  
Masafumi TAKAHASHI ◽  
Takeshi MITSUHASHI ◽  
Takaaki KATSUKI ◽  
Uichi IKEDA ◽  
Hidenobu TANAKA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document